The liquid biopsy market is forecasted to grow by USD 3696.4 mn during 2023-2028, accelerating at a CAGR of 25.2% during the forecast period. The report on the liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of cancer, growing focus on personalized medicine for cancer care, and advancements in liquid biopsy technologies.
Technavio's liquid biopsy market is segmented as below:
Market Scope |
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 19.78% |
CAGR | 25.2% |
Incremental Value | $3696.4mn |
ByApplication
- Cancer applications
- Non-cancer applications
ByTechnology
- CTC and ctDNA
- Exosome and RNA
ByGeography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing funding/investment for liquid biopsy as one of the prime reasons driving the liquid biopsy market growth during the next few years. Also, strategic partnerships among academic institutions, industries and M and A and emerging applications of liquid biopsy will lead to sizable demand in the market.
The report on the liquid biopsy market covers the following areas:
- Liquid biopsy market sizing
- Liquid biopsy market forecast
- Liquid biopsy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading liquid biopsy market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, ANGLE Plc, Bio Rad Laboratories Inc., Bio Techne Corp., Biocept Inc., Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corp., F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Inivata Ltd., MDXHEALTH SA, Mesa Laboratories Inc., Myriad Genetics Inc., Novogene Co. Ltd., OncoCyte Corp., QIAGEN NV, and SAGA Diagnostics AB. Also, the liquid biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.